Global Cardiac Biomarkers Market Forecast to 2027 with In-depth Company Profiles of Key Players and Upcoming Prominent Players - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 29, 2018--The “Global Cardiac Biomarkers Market Analysis & Trends - Industry Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.
The Global Cardiac Biomarkers Market is poised to grow strong during the forecast period 2017 to 2027.
Some of the prominent trends that the market is witnessing include rising use of cardiac biomarkers in poc testing, emerging cardiac biomarkers and technological advancements using cardiac biomarkers combinations.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
Report HighlightsThe report provides a detailed analysis on current and future market trends to identify the investment opportunities Market forecasts till 2027, using estimated market values as the base numbers Key market trends across the business segments, Regions and Countries Key developments and strategies observed in the market Market Dynamics such as Drivers, Restraints, Opportunities and other trends In-depth company profiles of key players and upcoming prominent players Growth prospects among the emerging nations through 2027 Market opportunities and recommendations for new investments
Key Topics Covered
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Application Analysis
1.6 End User Analysis
1.7 Strategic Benchmarking
1.8 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Rising use of cardiac biomarkers in POC testing
3.1.2 Emerging cardiac biomarkers
3.1.3 Technological advancements using cardiac biomarkers combinations
3.1.4 Growth Opportunities/Investment Opportunities
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
4 Cardiac Biomarkers Market, By Product
4.1 Myocardial muscle Creatine Kinase (CK-MB)
4.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
4.5 Ischemia-modified albumin (IMA)
4.6 Heart-type Fatty Acid Binding Protein (H-FABP)
4.7 LDH isoenzymes
4.8 Other Products
5 Cardiac Biomarkers Market, By Location of Testing
5.1 Point of Care Testing
5.2 Laboratory Testing
6 Cardiac Biomarkers Market, By Application
6.2 Congestive Heart Failure (CHF)
6.3 Acute Myocardial Infarction (AMI)
6.4 Acute Coronary Syndrome (ACS)
6.8 Atrial Fibrillation
6.9 Other Applications
7 Cardiac Biomarkers Market, By End-User
7.1 Diagnostic laboratories
7.2 Hospitals and clinics
8 Cardiac Biomarkers Market, By Geography
8.1 North America
8.3 Asia Pacific
8.4 Middle East
8.5 Latin America
8.6 Rest of the World (RoW)
9 Key Player Activities
9.1 Acquisitions & Mergers
9.2 Agreements, Partnerships, Collaborations and Joint Ventures
9.3 Product Launch & Expansions
9.4 Other Activities
10 Leading Companies
10.1 Abbott laboratories
10.2 Siemens Healthcare
10.3 Roche Diagnostics Corporation
10.4 Thermo Fisher Scientific
10.5 Becton, Dickinson And Co.
10.6 Beckman Coulter
10.8 Bio-Rad Laboratories
10.9 Randox laboratories
10.10 Boditech Med Inc.
10.11 Quidel Corporation
10.12 Ortho-Clinical Diagnostics, Inc.
10.13 BG Medicine, Inc.
10.14 Response Biomedical Corp
10.15 Trivitron Healthcare
10.16 Trinity Biotech
For more information about this report visit https://www.researchandmarkets.com/research/44ft4d/global_cardiac?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181129005639/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH CARDIOLOGY GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/29/2018 12:45 PM/DISC: 11/29/2018 12:45 PM